Ontology highlight
ABSTRACT: Background
Arteriovenous (AV) fistulas are considered the gold standard for ensuring safe and long-term vascular access in patients with haemodialysis-dependent end-stage renal disease. However, previous studies demonstrated that high-flow AV fistulas might add additional cardiovascular burden in the post-transplant setting, leading to frequent fistula closure in this population. Currently, there is no consensus regarding management of high-flow fistulas in post-transplant patients with stable kidney function. The present randomized controlled trial examines the effect of prophylactic AV fistula closure on high-output heart failure.Methods
Twenty-eight kidney transplant patients with stable graft function, absence of pre-existing severe cardiac failure, and brachial arteria
SUBMITTER: Hetz P
PROVIDER: S-EPMC7592949 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature